NuVasive, Inc. Sustainability Profile
NuVasive, Inc., a leading medical device company headquartered in the United States, specialises in innovative spinal surgery solutions. Founded in 1997, the company has established itself as a pioneer in the minimally invasive spine surgery sector, focusing on enhancing surgical outcomes and patient recovery. With a strong presence across North America, Europe, and Asia, NuVasive offers a comprehensive range of products and services, including advanced surgical instruments, biologics, and imaging technologies. Their unique approach to spinal surgery, characterised by proprietary technologies such as the XLIF® procedure, sets them apart in the competitive landscape. Recognised for their commitment to innovation, NuVasive has achieved significant milestones, including numerous patents and awards, solidifying their position as a trusted leader in the spinal device market.
DitchCarbon Score
How does NuVasive, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
NuVasive, Inc.'s score of 31 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
NuVasive, Inc.'s reported carbon emissions
NuVasive, Inc., headquartered in the US, has set ambitious climate commitments aimed at significantly reducing its carbon emissions. Although specific emissions data for the most recent year is not available, the company has outlined a clear strategy to achieve near-zero emissions for both Scope 1 and Scope 2 by the middle of this decade, specifically targeting the years 2023 to 2025. These commitments reflect NuVasive's proactive approach to sustainability, focusing on direct emissions from owned or controlled sources (Scope 1) and indirect emissions from the generation of purchased electricity, steam, heating, and cooling (Scope 2). The company has not disclosed any absolute emissions figures, which may be inherited from its parent company, Globus Medical, Inc., as part of its corporate family relationship. NuVasive's initiatives are part of a broader industry trend towards climate responsibility, aligning with global efforts to mitigate climate change. The company's commitment to reducing its carbon footprint underscores its dedication to environmental stewardship and sustainable practices within the medical device sector.
How Carbon Intensive is NuVasive, Inc.'s Industry?
How Carbon Intensive is NuVasive, Inc.'s Location?
NuVasive, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
NuVasive, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
